Global Cancer Therapeutics Market Outlook

Global Cancer Therapeutics Market Outlook

 

RELEASE DATE
28-Oct-2005
REGION
Global
Research Code: F404-01-00-00-00
SKU: HC01452-GL-MR_05946

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC01452-GL-MR_05946

$4,950.00

$3,712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

The Global Cancer Therapeutics Market is a fast growing market that is relying heavily on new drugs. The total therapeutic market is expected to grow from $23.1 billion in 2004 to $60.6 billion in 2011. The targeted therapy segment is providing the growth of the entire market with an expected compound annual growth rate of 24.1 percent for 2004-2011.

Table of Contents

Introduction

  • Introduction
  • Disclaimer
  • Certification
  • Contents
  • Top 15 Growth Cancer Therapeutics

Market Overview

  • Contents
  • Research Scope and Methodology
  • Abreviations
  • Segmentation
  • Targeted Therapy Segments
  • Targeted Therapy Definitions
  • Summary of Findings
  • Market Drivers (1)
  • Market Drivers (2)
  • Challenges and Strategies (1)
  • Challenges and Strategies (2)
  • Challenges and Strategies (3)
  • Challenges and Strategies (4)
  • Challenges and Strategies (5)

Total Market Forecasts

  • Contents
  • Total Market Forecasts
  • Total Market Forecasts by Therapeutic Class
  • US Forecasts by Therapeutic Class
  • Ex US Forecasts by Therapeutic Class
  • Cytotoxic Therapy Forecasts
  • Hormone Therapy Forecasts
  • Targeted Therapy Forecasts
  • Global Market Share Analysis
  • US Market Share Analysis
  • Ex US Market Share Analysis

NSCLC

  • Contents
  • Disease Overview
  • Epidemiology Trends
  • Incidence
  • Mortality
  • Treatment Overview
  • Common Drugs
  • Common Regimens
  • Treatment Diagram
  • Revenue Forecasts
  • Drug Development

Breast Cancer

  • Contents
  • Disease Overview
  • Epidemiology
  • Incidence
  • Mortality
  • Treatment Overview
  • Common Drugs
  • Common Regimens
  • Hormone Treatment Diagram
  • Metastatic Treatment Diagram
  • Revenue Forecasts
  • Drug Development

Colorectal Cancer

  • Contents
  • Disease Overview
  • Epidemiology
  • Incidence
  • Mortality
  • Treatment Overview
  • Common Drugs
  • Common Regimens
  • Treatment Diagram
  • Revenue Forecasts
  • Drug Development

Prostate Cancer

  • Contents
  • Disease Overview
  • Epidemiology
  • Incidence
  • Mortality
  • Treatment Overview
  • Common Drugs
  • Common Regimens
  • Treatment Diagram
  • Revenue Forecasts
  • Drug Development

Top 15 Growth Therapeutic Cancer Drugs (Overview; Indications Development and Forecasts)

  • Contents
  • Top 15 Growth Therapeutic Cancer Drugs
  • Rituxan/MabThera
  • Taxotere
  • Gleevec/Glivec
  • Eloxatin
  • Gemzar
  • Herceptin
  • Zometa
  • Casodex
  • Arimidex
  • Avastin
  • Camptosar/Campto
  • Temodar/Temodal
  • Xeloda
  • Femara
  • Erbitux

Recent Filings and Approvals

  • Contents
  • Recent Filings and Approvals

Key Late-Stage Pipeline Drugs

  • Contents
  • Key Late-Stage Pipeline Drugs

Awards

  • Contents
  • Frost & Sullivan Awards
  • Company of the Year
  • Product Innovation of the Year
  • Product-Line/Pipeline Strategy of the Year
  • Entrepreneurial Company of the Year
  • Business Development Strategy of the Year

Frost & Sullivan Capabilities

  • Contents
  • Our Capabilities I
  • Our Capabilities II
  • Our Consulting Clients
  • Growth Consulting
  • Growth Consulting Process
  • Growth Consulting Deliverables
  • Growth Partnership Service
  • Growth Partnership Services Platform